Cargando…
Correction: Reversal of immune-checkpoint inhibitor fulminant myocarditis using personalized-dose-adjusted abatacept and ruxolitinib: proof of concept
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9157334/ https://www.ncbi.nlm.nih.gov/pubmed/35640932 http://dx.doi.org/10.1136/jitc-2022-004699corr1 |
Sumario: |
---|